154 related articles for article (PubMed ID: 1318313)
21. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
22. Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. Comparison with another tumor promoter, phorbol ester.
Higuchi M; Aggarwal BB
J Biol Chem; 1993 Mar; 268(8):5624-31. PubMed ID: 8383675
[TBL] [Abstract][Full Text] [Related]
23. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
24. Differential binding of cAMP-responsive-element (CRE)-binding protein-1 and activating transcription factor-2 to a CRE-like element in the human tissue-type plasminogen activator (t-PA) gene promoter correlates with opposite regulation of t-PA by phorbol ester in HT-1080 and HeLa cells.
Costa M; Medcalf RL
Eur J Biochem; 1996 May; 237(3):532-8. PubMed ID: 8647095
[TBL] [Abstract][Full Text] [Related]
25. Okadaic acid-dependent induction of the urokinase-type plasminogen activator gene associated with stabilization and autoregulation of c-Jun.
Lee JS; Favre B; Hemmings BA; Kiefer B; Nagamine Y
J Biol Chem; 1994 Jan; 269(4):2887-94. PubMed ID: 8300623
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.
Heaton JH; Kathju S; Gelehrter TD
Mol Endocrinol; 1992 Jan; 6(1):53-60. PubMed ID: 1738371
[TBL] [Abstract][Full Text] [Related]
27. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.
van Hinsbergh VW; Vermeer M; Koolwijk P; Grimbergen J; Kooistra T
Blood; 1994 Nov; 84(9):2984-91. PubMed ID: 7949170
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
Schönthal A; Alberts AS; Frost JA; Feramisco JR
New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
[TBL] [Abstract][Full Text] [Related]
29. Okadaic acid, a phosphatase inhibitor, enhances the phorbol ester-induced interleukin-1 beta expression via an AP-1-mediated mechanism.
Hurme M; Matikainen S
Scand J Immunol; 1993 Dec; 38(6):570-4. PubMed ID: 8256116
[TBL] [Abstract][Full Text] [Related]
30. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid.
Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D
Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903
[TBL] [Abstract][Full Text] [Related]
31. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils.
Politis I; Zavizjon B; Cheli F; Baldi A
J Dairy Res; 2002 May; 69(2):195-204. PubMed ID: 12222798
[TBL] [Abstract][Full Text] [Related]
32. Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases.
Kim SJ; Lafyatis R; Kim KY; Angel P; Fujiki H; Karin M; Sporn MB; Roberts AB
Cell Regul; 1990 Feb; 1(3):269-78. PubMed ID: 1966042
[TBL] [Abstract][Full Text] [Related]
33. Regulation of human tissue-type plasminogen activator gene transcription by epidermal growth factor and 3',5'-cyclic adenosine monophosphate.
Medcalf RL; Schleuning WD
Mol Endocrinol; 1991 Dec; 5(12):1773-9. PubMed ID: 1665201
[TBL] [Abstract][Full Text] [Related]
34. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor.
Scarpati EM; Sadler JE
J Biol Chem; 1989 Dec; 264(34):20705-13. PubMed ID: 2555368
[TBL] [Abstract][Full Text] [Related]
35. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
[TBL] [Abstract][Full Text] [Related]
36. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
38. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
39. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
Niiya K; Sakuragawa N
Nihon Rinsho; 1992 Feb; 50(2):325-9. PubMed ID: 1319513
[TBL] [Abstract][Full Text] [Related]
40. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
